Bioequivalence and the immunogenicity of biopharmaceuticals.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 457, doi. 10.1038/nrd818
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2002 AND VI 1 AND IP 6
Results: 20
1
2
Microarrays: Sugar coating.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 408, doi. 10.1038/nrd815
- By:
- Publication type:
- Article
3
Anti-inflammatories: Heart of the matter.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 407, doi. 10.1038/nrd816
- By:
- Publication type:
- Article
4
Encoding microcarriers: present and future technologies.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 447, doi. 10.1038/nrd817
- By:
- Publication type:
- Article
5
Obesity and diabetes: Slimming down without DGAT.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 408, doi. 10.1038/nrd814
- By:
- Publication type:
- Article
6
Angiogenesis modulation in cancer research: novel clinical approaches.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 415, doi. 10.1038/nrd819
- By:
- Publication type:
- Article
7
New treatments for copd.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 437, doi. 10.1038/nrd820
- By:
- Publication type:
- Article
8
Novel animal-health drug targets from ligand-gated chloride channels.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 427, doi. 10.1038/nrd821
- By:
- Publication type:
- Article
9
Combinatorial chemistry: Survival of the fittest.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 412, doi. 10.1038/nrd829
- By:
- Publication type:
- Article
10
Outlook: Preclinical safety evaluation of biotechnology-derived pharmaceuticals.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 469, doi. 10.1038/nrd822
- By:
- Publication type:
- Article
11
Science and society: The impact of pharmacogenetics and pharmacogenomics on drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 463, doi. 10.1038/nrd823
- By:
- Publication type:
- Article
12
Hypolipidaemic drugs: Antagonizing the bile-acid receptor.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 411, doi. 10.1038/nrd826
- By:
- Publication type:
- Article
13
Microarrays: Validation on target.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 409, doi. 10.1038/nrd827
- By:
- Publication type:
- Article
14
Bone diseases: Self control.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 410, doi. 10.1038/nrd828
- By:
- Publication type:
- Article
15
IN BRIEF.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 411, doi. 10.1038/nrd830
- Publication type:
- Article
16
FROM THE ANALYST'S COUCH: Drugs that target angiogenesis.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 413, doi. 10.1038/nrd824
- By:
- Publication type:
- Article
17
PATENT WATCH.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 412
- Publication type:
- Article
18
DEALING WITH THE DATA DELUGE.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 479, doi. 10.1038/nrd832
- By:
- Publication type:
- Article
19
Neurodegenerative disease: The nature of the beast.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 6, p. 410, doi. 10.1038/nrd833
- By:
- Publication type:
- Article
20
Why we need zoos.
- Published in:
- 2002
- Publication type:
- Editorial